Ignite Creation Date:
2024-05-05 @ 6:32 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00509665
Status:
COMPLETED
Last Update Posted:
2018-07-12
First Post:
2007-07-30
Brief Title:
Gemcitabine and Doxorubicin in Treating Patients With Recurrent or Progressive Head and Neck Cancer
Sponsor:
Medical University of South Carolina
Organization:
Medical University of South Carolina
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Head and Neck Cancer |
Keywords:
| Name | View |
|---|---|
| recurrent squamous cell carcinoma of the oropharynx | View |
| recurrent squamous cell carcinoma of the hypopharynx | View |
| recurrent squamous cell carcinoma of the larynx | View |
| recurrent verrucous carcinoma of the larynx | View |
| recurrent adenoid cystic carcinoma of the oral cavity | View |
| recurrent basal cell carcinoma of the lip | View |
| recurrent mucoepidermoid carcinoma of the oral cavity | View |
| recurrent squamous cell carcinoma of the lip and oral cavity | View |
| recurrent verrucous carcinoma of the oral cavity | View |
| recurrent metastatic squamous neck cancer with occult primary | View |
| recurrent lymphoepithelioma of the nasopharynx | View |
| recurrent squamous cell carcinoma of the nasopharynx | View |
| recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity | View |
| recurrent inverted papilloma of the paranasal sinus and nasal cavity | View |
| recurrent midline lethal granuloma of the paranasal sinus and nasal cavity | View |
| recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity | View |
| recurrent salivary gland cancer | View |
| recurrent lymphoepithelioma of the oropharynx | View |